Daniel E. Lage, Ryan D. Nipp, Sara M. D'Arpino, Samantha M. Moran, P. Connor Johnson, Risa L. Wong, Ephraim P. Hochberg, Barbara J. Cashavelly, Holly S. Martinson, David P. Ryan, Jennifer S. Temel, and Areej El-Jawahri, Massachusetts General Hospital Cancer Center; Daniel E. Lage, Ryan D. Nipp, P. Connor Johnson, Risa L. Wong, Ephraim P. Hochberg, Lara N. Traeger, Vicki A. Jackson, Joseph A. Greer, David P. Ryan, Jennifer S. Temel, and Areej El-Jawahri, Harvard Medical School; Lara N. Traeger, Vicki A. Jackson, and Joseph A. Greer, Massachusetts General Hospital, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
J Clin Oncol. 2018 Jan 1;36(1):76-82. doi: 10.1200/JCO.2017.74.0340. Epub 2017 Oct 25.
Purpose Patients with advanced cancer experience potentially burdensome transitions of care after hospitalizations. We examined predictors of discharge location and assessed the relationship between discharge location and survival in this population. Methods We conducted a prospective study of 932 patients with advanced cancer who experienced an unplanned hospitalization between September 2014 and March 2016. Upon admission, we assessed patients' physical symptoms (Edmonton Symptom Assessment System) and psychological distress (Patient Health Questionnaire-4). The primary outcome was discharge location (home without hospice, postacute care [PAC], or hospice [any setting]). The secondary outcome was survival. Results Of 932 patients, 726 (77.9%) were discharged home without hospice, 118 (12.7%) were discharged to PAC, and 88 (9.4%) to hospice. Those discharged to PAC and hospice reported high rates of severe symptoms, including dyspnea, constipation, low appetite, fatigue, depression, and anxiety. Using logistic regression, patients discharged to PAC or hospice versus home without hospice were more likely to be older (odds ratio [OR], 1.03; 95% CI, 1.02 to 1.05; P < .001), live alone (OR, 1.95; 95% CI, 1.25 to 3.02; P < .003), have impaired mobility (OR, 5.08; 95% CI, 3.46 to 7.45; P < .001), longer hospital stays (OR, 1.15; 95% CI, 1.11 to 1.20; P < .001), higher Edmonton Symptom Assessment System physical symptoms (OR, 1.02; 95% CI, 1.003 to 1.032; P < .017), and higher Patient Health Questionnaire-4 depression symptoms (OR, 1.13; 95% CI, 1.01 to 1.25; P < .027). Patients discharged to hospice rather than PAC were more likely to receive palliative care consultation (OR, 4.44; 95% CI, 2.12 to 9.29; P < .001) and have shorter hospital stays (OR, 0.84; 95% CI, 0.77 to 0.91; P < .001). Patients discharged to PAC versus home had lower survival (hazard ratio, 1.53; 95% CI, 1.22 to 1.93; P < .001). Conclusion Patients with advanced cancer who were discharged to PAC facilities and hospice had substantial physical and psychological symptom burden, impaired physical function, and inferior survival compared with those discharged to home. These patients may benefit from interventions to enhance their quality of life and care.
目的 患有晚期癌症的患者在住院后可能会经历潜在的负担过重的护理过渡。我们研究了出院地点的预测因素,并评估了该人群出院地点与生存之间的关系。
方法 我们对 2014 年 9 月至 2016 年 3 月期间经历非计划性住院的 932 名晚期癌症患者进行了前瞻性研究。入院时,我们评估了患者的身体症状(埃德蒙顿症状评估系统)和心理困扰(患者健康问卷-4)。主要结局是出院地点(无临终关怀的家庭、急性后期护理[PAC]或临终关怀[任何设置])。次要结局是生存。
结果 在 932 名患者中,726 名(77.9%)出院时无临终关怀,118 名(12.7%)出院至 PAC,88 名(9.4%)出院至临终关怀。出院至 PAC 和临终关怀的患者报告了严重症状的高发生率,包括呼吸困难、便秘、食欲不振、疲劳、抑郁和焦虑。使用逻辑回归,与出院至无临终关怀家庭的患者相比,出院至 PAC 或临终关怀的患者更可能年龄较大(优势比[OR],1.03;95%置信区间[CI],1.02 至 1.05;P<.001)、独居(OR,1.95;95%CI,1.25 至 3.02;P<.003)、行动能力受损(OR,5.08;95%CI,3.46 至 7.45;P<.001)、住院时间较长(OR,1.15;95%CI,1.11 至 1.20;P<.001)、埃德蒙顿症状评估系统身体症状评分较高(OR,1.02;95%CI,1.003 至 1.032;P<.017)和患者健康问卷-4 抑郁症状评分较高(OR,1.13;95%CI,1.01 至 1.25;P<.027)。与 PAC 相比,出院至临终关怀的患者更可能接受姑息治疗咨询(OR,4.44;95%CI,2.12 至 9.29;P<.001)和住院时间较短(OR,0.84;95%CI,0.77 至 0.91;P<.001)。与出院至家庭的患者相比,出院至 PAC 的患者生存率较低(危险比,1.53;95%CI,1.22 至 1.93;P<.001)。
结论 与出院至家庭的患者相比,出院至 PAC 设施和临终关怀的晚期癌症患者身体和心理症状负担更重,身体功能受损,生存时间更短。这些患者可能受益于改善生活质量和护理的干预措施。